EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate?

Babbette Lamarca, Justin Brewer, Kedra Wallace

International Journal of Interferon, Cytokine and Mediator Research · 2011

DOI: 10.2147/ijicmr.s16320 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Interferon, Cytokine and Mediator Research, 2011. Verfasst von Babbette Lamarca und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Mississippi Medical Center, Jackson, MS, USA. Die Arbeit wurde bisher 50-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: NHLBI NIH HHS, NICHD NIH HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, University of Mississippi Medical Center, Jackson, MS, USA.

Förderung

  • NHLBI NIH HHS
  • NICHD NIH HHS

Zitieren

APA

Lamarca, B., Brewer, J., & Wallace, K. (2011). IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate?. International Journal of Interferon, Cytokine and Mediator Research. https://doi.org/10.2147/ijicmr.s16320

Vancouver

Lamarca B, Brewer J, Wallace K. IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate?. International Journal of Interferon, Cytokine and Mediator Research. 2011. doi:10.2147/ijicmr.s16320

BibTeX
@article{Lamarca2011,
  author = {Lamarca, Babbette and Brewer, Justin and Wallace, Kedra},
  title = {IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate?},
  journal = {International Journal of Interferon, Cytokine and Mediator Research},
  year = {2011},
  doi = {10.2147/ijicmr.s16320}
}
Kostenlos starten →